Literature DB >> 12942560

Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma.

Anna H Wu1, Chiu-Chen Tseng, Leslie Bernstein.   

Abstract

BACKGROUND: Since the 1970s, incidence rates of esophageal and gastric cardia adenocarcinoma have risen substantially. Reasons for the increasing trends are not well understood.
METHODS: A population-based, case-control study that included esophageal adenocarcinomas (n = 222), gastric cardia adenocarcinomas (n = 277), distal gastric adenocarcinomas (n = 443), and 1356 controls was conducted in Los Angeles County. Unconditional logistic regression was used to calculate odds ratios (ORs) and corresponding 95% confidence intervals (CIs) for the 3 tumor types.
RESULTS: After adjustment for demographic factors, smoking, and body size, both hiatal hernia and reflux symptoms emerged as significant independent risk factors. Risk of esophageal adenocarcinoma was increased 3-fold (adjusted OR, 3.61; 95% CI, 2.49-5.25) among those who had reflux symptoms but did not have hiatal hernia, 6-fold (adjusted OR, 5.85; 95% CI, 3.18-10.75) among those who had hiatal hernia but did not have reflux symptoms, and 8-fold (adjusted OR, 8.11; 95% CI, 4.75-13.87) among those who had both reflux symptoms and hiatal hernia. A similar risk pattern was found in relation to history of hiatal hernia and other reflux conditions. A more modest but still significant risk pattern was observed for gastric cardia adenocarcinoma. Among control subjects, there was a significant and positive association between increasing body mass index and history of hiatal hernia and/or reflux symptoms.
CONCLUSIONS: Hiatal hernia, in combination with other reflux conditions and symptoms, was associated strongly with the risk of esophageal adenocarcinoma. These associations were more modest for gastric cardia adenocarcinomas. A significant and positive association between body size and history of hiatal hernia/reflux symptoms also was observed. Copyright 2003 American Cancer Society.

Entities:  

Mesh:

Year:  2003        PMID: 12942560     DOI: 10.1002/cncr.11568

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  58 in total

1.  Diabetes and risk of esophageal and gastric adenocarcinomas.

Authors:  Xuejuan Jiang; Leslie Bernstein; Chiu-Chen Tseng; Anna H Wu
Journal:  Int J Cancer       Date:  2012-01-11       Impact factor: 7.396

2.  Oesophageal cancer and gastro-oesophageal reflux: what is the relationship?

Authors:  J Lagergren
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

3.  Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.

Authors:  L A García Rodríguez; J Lagergren; M Lindblad
Journal:  Gut       Date:  2006-06-19       Impact factor: 23.059

Review 4.  Acid inhibitory medication and risk of gastric and oesophageal cancer.

Authors:  K E L McColl
Journal:  Gut       Date:  2006-11       Impact factor: 23.059

5.  Have patients with esophagitis got an increased risk of adenocarcinoma? Results from a population-based study.

Authors:  Seamus J Murphy; Lesley A Anderson; Brian T Johnston; Deirdre A Fitzpatrick; Peter Rg Watson; Pauline Monaghan; Liam J Murray
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

6.  Shape of Barrett's epithelium is associated with prevalence of erosive esophagitis.

Authors:  Tomoyuki Akiyama; Masahiko Inamori; Hiroshi Iida; Hiroki Endo; Kunihiro Hosono; Yasunari Sakamoto; Koji Fujita; Masato Yoneda; Hirokazu Takahashi; Tomoko Koide; Chikako Tokoro; Ayumu Goto; Yasunobu Abe; Takeshi Shimamura; Noritoshi Kobayashi; Kensuke Kubota; Satoru Saito; Atsushi Nakajima
Journal:  World J Gastroenterol       Date:  2010-01-28       Impact factor: 5.742

7.  Effect of high fat-diet and obesity on gastrointestinal motility.

Authors:  Mazen Al Mushref; Shanthi Srinivasan
Journal:  Ann Transl Med       Date:  2013-07-01

8.  Targeting chemokine pathways in esophageal adenocarcinoma.

Authors:  Makardhwaj S Shrivastava; Zulfiqar Hussain; Orsolya Giricz; Niraj Shenoy; Rahul Polineni; Anirban Maitra; Amit Verma
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 9.  Surgical management of esophagogastric junction tumors.

Authors:  Burkhard H A von Rahden; Hubert J Stein; J Rüdiger Siewert
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

10.  The pathophysiological mechanisms of GERD in the obese patient.

Authors:  Ronnie Fass
Journal:  Dig Dis Sci       Date:  2008-07-29       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.